EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

HOXA5 Derives the Malignant Progression and Cisplatin Resistance of Esophageal Squamous Cell Carcinoma by Regulating USP18‐Mediated IFI27 Deubiquitination

Qiang Wang, Shiheng Ren iD, Zheng Pan, Yuxin Chen, Xiangyan Liu iD

Thoracic Cancer · 2025

DOI: 10.1111/1759-7714.70013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thoracic Cancer, 2025. Verfasst von Qiang Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China. Hauptthemen laut MEDLINE: Cisplatin, Esophageal Squamous Cell Carcinoma, Ubiquitin Thiolesterase, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Shandong Provincial Natural Science Foundation, China, Natural Science Foundation of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chemo‐resistance is a major obstacle to the treatment of esophageal squamous cell carcinoma (ESCC). Interferon alpha‐inducible protein 27 (IFI27) has been reported to be associated with ESCC progression. This study is designed to explore the role and mechanism of IFI27 in the cisplatin (DDP) resistance of ESCC.

Methods

IFI27 and Ubiquitin‐specific peptidase 18 (USP18) levels were detected by real‐time quantitative polymerase chain reaction (RT‐qPCR). IFI27, multidrug resistance‐associated protein 1 (MRP1), USP18, and Homeobox A5 (HOXA5) protein levels were determined using western blot. DDP resistance, cell viability, proliferation, apoptosis, invasion, and migration were assessed using MTT, EdU, flow cytometry, transwell, and wound healing. Interaction between USP18 and IFI27 was verified using Co‐immunoprecipitation (CoIP) assay. Binding between HOXA5 and USP18 promoter was predicted by JASPAR and validated using Chromatin immunoprecipitation (ChIP) and dual‐luciferase reporter assays.

Results

IFI27 was upregulated in DDP‐resistant ESCC tissues and cells. IFI27 knockdown repressed DDP resistance, cell proliferation, invasion, migration, and induced cell apoptosis in vitro. Mechanistically, USP18 induced the deubiquitination of IFI27 and prevented its degradation. Furthermore, HOXA5 was a transcription factor of USP18 and activated the transcriptional activity of USP18 via binding to its promoter region.

Conclusion

USP18 transcriptionally mediated by HOXA5 could promote cell malignant behaviors and DDP resistance through deubiquitinating IFI27, providing a promising therapeutic target for ESCC treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinEsophageal Squamous Cell CarcinomaUbiquitin ThiolesteraseDrug Resistance, NeoplasmEsophageal NeoplasmsHomeodomain ProteinsHumansUbiquitinationCell ProliferationDisease ProgressionGene Expression Regulation, NeoplasticMaleApoptosisCell Line, TumorFemaleMembrane Proteins

Stichwörter der Autor:innen

DDP resistance mechanismESCCHOXA5IFI27USP18deubiquitinationproliferation

Substanzen

CisplatinUbiquitin ThiolesteraseUSP18 protein, humanIFI27 protein, humanHomeodomain ProteinsMembrane Proteins

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
  • Department of Thoracic Surgery, The People's Hospital of Laoling City, Dezhou, China.
  • Department of Thoracic Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.

ORCID-Profile: Shiheng Ren, Xiangyan Liu

Förderung

  • Shandong Provincial Natural Science Foundation, China
  • Natural Science Foundation of Shandong Province

Zitieren

APA

Wang, Q., Ren, S., Pan, Z., Chen, Y., & Liu, X. (2025). HOXA5 Derives the Malignant Progression and Cisplatin Resistance of Esophageal Squamous Cell Carcinoma by Regulating USP18‐Mediated IFI27 Deubiquitination. Thoracic Cancer. https://doi.org/10.1111/1759-7714.70013

Vancouver

Wang Q, Ren S, Pan Z, Chen Y, Liu X. HOXA5 Derives the Malignant Progression and Cisplatin Resistance of Esophageal Squamous Cell Carcinoma by Regulating USP18‐Mediated IFI27 Deubiquitination. Thoracic Cancer. 2025. doi:10.1111/1759-7714.70013

BibTeX
@article{Wang2025,
  author = {Wang, Qiang and Ren, Shiheng and Pan, Zheng and Chen, Yuxin and Liu, Xiangyan},
  title = {HOXA5 Derives the Malignant Progression and Cisplatin Resistance of Esophageal Squamous Cell Carcinoma by Regulating USP18‐Mediated IFI27 Deubiquitination},
  journal = {Thoracic Cancer},
  year = {2025},
  doi = {10.1111/1759-7714.70013}
}
Kostenlos starten →